In the setting of widespread availability of excess calories and more sedentary lifestyles 2,3,4,5 as exists in much of the modern worldmechanisms that reduce muscle mass to conserve energy are counter-productive, and unfortunately result in higher fat deposition and obesity, and can exacerbate the risk of sarcopenia 6
This article examines the current state of knowledge regarding tirzepatide for binge eating disorder, including its mechanism of action, theoretical benefits, significant risks, and the critical importance of evidence-based psychological treatments
Bethel MA, Diaz R, Castellana N, Bhattacharya I, Gerstein HC, Lakshmanan MC (2021) HbA 1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression
Weight Loss Drug Class Action Eligibility Criteria To join a weight loss drug class action lawsuit, patients must prove that they used or were prescribed a GLP-1 receptor agonist such as Ozempic, Wegovy, or Rybelsus and then suffered injuries potentially linked to the drug